Various aspects of the relationship between vitiligo and the COVID‐19 pandemic or SARS‐CoV‐2 vaccines: Clinical pearls for dermatologists

Background Coronavirus disease 2019 (COVID‐19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo. Aim and Method Here, we present different aspects of relationship between SARS‐CoV‐2 infection or its associated vaccines and vitiligo and aim to provide solut...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cosmetic dermatology 2023-04, Vol.22 (4), p.1152-1156
Main Authors: Aryanian, Zeinab, Balighi, Kamran, Hatami, Parvaneh, Goodarzi, Azadeh, Janbakhsh, Alireza, Afshar, Zeinab Mohseni
Format: Article
Language:English
Subjects:
biologic agents
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
COVID‐19 vaccine
Dermatologists
Humans
Hypopigmentation
immunosuppressant agents
Mortality
Pandemics
Pandemics - prevention & control
SARS-CoV-2
Vaccines
Vitiligo
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Coronavirus disease 2019 (COVID‐19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo. Aim and Method Here, we present different aspects of relationship between SARS‐CoV‐2 infection or its associated vaccines and vitiligo and aim to provide solutions to overcome the potential challenges. Results and Conclusion In brief, as the benefits overweigh the risks and since vaccine‐triggered de novo or flares of vitiligo are uncommon and benign, these patients are recommended to get SARS‐CoV‐2 vaccines. Moreover, in individuals with previously recognized vitiligo, who are at risk of developing SARS‐CoV‐2 infection or those who are currently infected, special dermatologic consultation is needed in order to balance the immunosuppressive agents in their therapeutic regimen to prevent COVID‐related morbidity and mortality.
ISSN:1473-2130
1473-2165
DOI:10.1111/jocd.15550